Providing immediate CD4 count results at HIV testing improves ART initiation

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 3, 2011, Pages

  Faal, Mamsallah ^a   Naidoo, Nicolette ^a   Glencross, Deborah K ^b,c   Venter, Willem D F ^a   Osih, Regina ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Department of Human Genetics   (South Africa)

Author keywords

CD4 monitoring; loss to initiation; point of care CD4; point of care diagnostics; pre ART loss to care; retention in care

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; FLOW CYTOMETRY; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PRIORITY JOURNAL; RISK ASSESSMENT; SERODIAGNOSIS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; SOUTH AFRICA; TIME FACTORS;

EID: 80054930239     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182303921     Document Type: Article

References (23)

1. Country Situational Analysis: South Africa. Joint United Nations Programme on HIV/AIDS. Available at: http://www.unaids.org/en/regionscountries/ countries/southafrica/. Accessed June 19, 2011.
2. Partnership to Fight HIV/AIDS in South Africa. The United States President's Emergency Plan for AIDS Relief. Available at: http://www. pepfar.gov/countries/southafrica/. Accessed June 19, 2011.
3. Country data:South Africa. U.S. Global Health Policy and Henry J. Kaiser Family Foundation. Available at: http://www.globalhealthfacts.org/data/-country/ profile.aspx?loc=195. Accessed June 19, 2011.
4. HIV & AIDS and STI Strategic Plan for South Africa 2007-2011. National Department of Health, South Africa. Available at: http://www.info.gov. za/otherdocs/2007/aidsplan2007/index.html. Accessed June 19, 2011.
5. Bassett IV, Regan S, Chetty S, et al. Who starts antiretroviral therapy in Durban, South Africa? .not everyone who should. AIDS. 2010;24 (suppl 1):S37-S44.
6. Micek MA, Gimbel-Sherr K, Baptista AJ, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009;52:397-405.
7. Losina E, Bassett IV, Giddy J, et al. The 'ART' of Linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS Med. 2009;5:e9538.
8. Dalal RP, Macphail C, Mqhayi M, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;47: 101-107. (Pubitemid 351619376)
9. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2008;4:e298.
10. Maskew M, Macphail P, Menezes C, et al. Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 97:853-857.
11. Lawn S, Hames AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897-1902.
12. Personal communication: Jaffer A. Inner City Monitoring and Evaluation Data 2007/2008-Wits Reproductive Health and HIV Institute.
13. Rosen S, Ketlhapile M. Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa. Trop Med Int Health. 2010; 15:98-104.
14. Zachariah R, Reid SD, Chaillet P, et al. Viewpoint: why do we need a point-of-care CD4 test for low income countries? Trop Med Int Health. 2011;16:37-41.
15. Mokone G, Coetzee LM, Lawrie D, et al. Comparison of Point-of-Care CD4 technologies to accredited high-volume reference laboratory testing (PLG/CD4). Presented at: 4th International Workshop on HIV treatment, Pathogenesis and Prevention Research in Resource Poor Settings; July 2010; Maputo, Mozambique.
16. Pattanapanysat K, Sukapirom K, Rowanisatsat L, et al. New BDFACSCount CD4 Reagent system for simultaneous enumeration of percent and absolute CD4 T+ lymphocytes in HIV-1 infected pediatric patients. Cytometry B Clin Cytom. 2008;74(suppl 1):S98-S106. (Pubitemid 351569277)
17. Glencross DK, Aggett HM, Stevens WS, et al. African Regional External Quality Assessment (AFREQAS) for CD4 T-cell enumeration: development outcomes and performance of laboratories. Cytometry B Clin Cytom. 2008;74(suppl 1):S69-S79. (Pubitemid 351569274)
18. Glencross K, Janossy G, Coetzee LM, et al. Large-scale affordable Pan-Leucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African National comprehensive care, treatment and management programme for HIV and AIDS. Cytometry B Clin Cytom. 2008;74(suppl 1):S40-S51. (Pubitemid 351569271)
19. National Antiretroviral Treatment Guidelines 2004. National Department of Health, South Africa. Available at: http://www.doh.gov.za/docs/index. html. Accessed June 19, 2010.
20. Larson BA, Brennan A, McNamara L, et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010;15:43-47.
21. Krebs DW, Chi BH, Mulenga Y, et al. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care. 2008;20:311-317. (Pubitemid 351451247)
22. Lessels RJ, Mutevedzi PC, Cooke JS, et al. Retention in HIV care for individuals not yet eligible for antiretroviral therapy: Rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2011;56:79-86.
23. Ahonkhai A, Noubary F, Munro A, et al. Not all are lost: early death, care interruption, and loss to follow-up in a large South African community treatment program. Presented at: Eighteenth Conference on Retroviruses and Opportunistic Infections; 2011; Boston, MA. Abstract 1014.